ENDPOINTS

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

A small Oakland, CA-based biotech hoping to take on the sprawling landscape of substance use disorders and addiction has reeled in $70 million. The drug development startup, named Tempero Bio, secured the Series B to ...

Mar 24, 2025 - 12:02
 0
Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders
A small Oakland, CA-based biotech hoping to take on the sprawling landscape of substance use disorders and addiction has reeled in $70 million. The drug development startup, named Tempero Bio, secured the Series B to ...
Read More

Tags:

Previous Article

Apple would probably prefer you didn’t see this $510 MacBook Air deal

Next Article

Winds on an ultrahot planet challenge climate models

Related Posts

FDA lifts hold on Entrada's Duchenne drug after two years

FDA lifts hold on Entrada's Duchenne drug after two years

Feb 24, 2025  0

Updated: Judge halts NIH payment cuts nationwide after groups, 22 states sue

Updated: Judge halts NIH payment cuts nationwide after ...

Feb 11, 2025  0

Novo Nordisk looks into starting GLP-1 drug trials for addiction

Novo Nordisk looks into starting GLP-1 drug trials for ...

Mar 6, 2025  0